ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 015351909.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,199,000 | -15.0% | 28,300 | -29.2% | 0.01% | -33.3% |
| Q1 2021 | $6,116,000 | -90.1% | 40,000 | -89.9% | 0.01% | -91.6% |
| Q4 2020 | $61,871,000 | +74.0% | 396,000 | +27.5% | 0.11% | -4.5% |
| Q3 2020 | $35,553,000 | +36.2% | 310,700 | +33.6% | 0.11% | -7.4% |
| Q2 2020 | $26,107,000 | +38.1% | 232,600 | +10.5% | 0.12% | -20.9% |
| Q1 2020 | $18,901,000 | +170.1% | 210,500 | +225.3% | 0.15% | +218.8% |
| Q4 2019 | $6,997,000 | -36.2% | 64,700 | -42.2% | 0.05% | -46.1% |
| Q3 2019 | $10,959,000 | +85.5% | 111,900 | +148.1% | 0.09% | +67.9% |
| Q2 2019 | $5,907,000 | +515.3% | 45,100 | +535.2% | 0.05% | +381.8% |
| Q1 2019 | $960,000 | -53.3% | 7,100 | -66.4% | 0.01% | -38.9% |
| Q4 2018 | $2,054,000 | +20.1% | 21,100 | +71.5% | 0.02% | +28.6% |
| Q3 2018 | $1,710,000 | -52.0% | 12,300 | -57.1% | 0.01% | -53.3% |
| Q2 2018 | $3,563,000 | -84.5% | 28,700 | -86.1% | 0.03% | -87.1% |
| Q1 2018 | $23,005,000 | +543.3% | 206,400 | +590.3% | 0.23% | +828.0% |
| Q4 2017 | $3,576,000 | -77.3% | 29,900 | -73.4% | 0.02% | -82.5% |
| Q3 2017 | $15,783,000 | +12.5% | 112,500 | -2.4% | 0.14% | -2.1% |
| Q2 2017 | $14,029,000 | +1930.2% | 115,300 | +1922.8% | 0.15% | +1725.0% |
| Q1 2017 | $691,000 | -69.3% | 5,700 | -69.0% | 0.01% | -63.6% |
| Q4 2016 | $2,251,000 | – | 18,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|